|
The U.S. counter terrorism apparatus was used to monitor the Occupy Movement nationwide. Click here to read CMD's special report, based on a year-long investigation. |
Project HOPE
Project HOPE "is unique among international organizations in that we have always worked across the health spectrum in a wide variety of settings – from the family and community levels to the tertiary care level – training traditional birth attendants and community health volunteers where resources are limited and cardiac surgeons and biomedical engineers where technology is appropriate.
"The health challenges facing us today are very different from those in 1958 – when Project HOPE first pioneered medical diplomacy by developing friendly relationships with peoples of different cultures and orientations, through sharing of medical knowledge and treating patients alongside health professional counterparts. Over the past five decades, however, we have demonstrated our ability to develop and permanently institute long-term solutions to pressing health problems, the true essence of helping people help themselves." [1]
Project HOPE owns and publishes the health policy journal Health Affairs.
Contents |
Leadership
[2] John P. Howe III, M.D is President and CEO of Project HOPE.
Directors
- Charles A. Sanders, M.D. - Chairman (Retired Chairman & CEO, GlaxoSmithKline)
- George B. Abercrombie (President and CEO, Hoffmann-LaRoche Inc.)
- Arno Bohn (Bohn Consult GmbH)
- William F. Brandt, Jr. (Retired Chairman and CEO, American Woodmark)
- Nancy T. Chang, Ph. D. (President, Apex Enterprises)
- Richard T. Clark (Chairman, President and CEO, Merck & Co., Inc.)
- Mrs. Edward N. Cole (Briar Patch Ranch)
- Sue Desmond-Hellmann, M.D. (President, Product Development, Genentech, Inc.)
- John W. Galiardo (Retired Vice Chairman, Becton, Dickinson and Company)
- Jack M. Gill, Ph.D. (President, The Gill Foundation)
- Robert A. Ingram (Vice Chairman, GlaxoSmithKline)
- Nancy A. Larson (Vice President and General Manager, Skin & Wound Care Division, 3M Company)
- Joseph M. Mahady (President, Global Business, Wyeth Pharmaceuticals; Senior Vice President, Wyeth)
- Gerhard N. Mayr (Retired Executive Vice President, Pharmaceutical Operations, Eli Lilly & Company)
- J. Michael McQuade Ph.D. (Senior Vice President, Science and Technology, United Technologies Corporation)
- Viren Mehta, Pharm. D (Mehta Partners LLC)
- Walter G. Montgomery (Partner and CEO, Robinson Lerer & Montgomery)
- Dayton Ogden (Chairman, SpencerStuart Worldwide)
- Steven B. Pfeiffer, Esq. (Chair of the Executive Committee, Fulbright & Jaworski LLP)
- James E. Preston (Retired Chairman and CEO, Avon Products, Inc.)
- Stephen H. Rusckowski (Chief Executive Officer, Philips Medical Systems)
- Curt M. Selquist (Company Group Chairman, Johnson & Johnson Healthcare Systems)
- Louis W. Sullivan M.D. (President Emeritus, Morehouse School of Medicine)
- Henri A. Termeer (Chairman, President & CEO, Genzyme Corporation)
- Karen Welke (Retired Group Vice President, 3M Company)
- Bradley A. J. Wilson (Chairman, PharmaKodex Ltd.)
Contact
Project HOPE
255 Carter Hall Lane
Millwood, VA 22646
Phone: 1-800-544-4673 (HOPE)
Web: http://www.projecthope.org/
Resources and articles
Related Sourcewatch articles
References
- ↑ Mission, Project HOPE, accessed March 2, 2009.
- ↑ From Leadership, Project HOPE, accessed September 2009
